Contents:


Foreword

Harm Reduction Therapy Thrives in Beirut, Lebanon (and Iran and England and France and Switzerland and Egypt...), Andrew Tatarsky, PhD


Opening Session

    Ms Sarah Trad
    Jawad Mahjour, MD
    Ahmad Mohit, MD
    Mr Abdel Salam Marini
    Ms Nayla Moawwad
    Mohammad Jawad Khalifeh, MD

Maintenance Programs

- Opiate Addiction: Bad News, but also Very Good News, Robert Newman, MD, MPH

- Bilan de quarante ans de traitements de substitution par la méthadone, Jean-Jacques Déglon, MD

- Discussion, Chawki Azouri, MD

- La médecine des addictions : une révolution pacifique, William Lowenstein, MD

- Discussion, Josyan Madi-Skaff, MD


Therapeutic Models

- The Matrix Model: An Intensive Structured Outpatient Approach, Richard Rawson, PhD

- Interpersonal Relapse Prevention: CAT and Addictions Treatment, Mr Tim Leighton

- Discussion, Shahe Kazarian, MD

- Bases cliniques et conceptuelles des soins en addictologie, Alain Morel, MD

- Harm Reduction Psychotherapy: Extending the Reach of Traditional Substance Use Treatment, Andrew Tatarsky, PhD

- Accompagner et non pas surveiller, Chawki Azouri, MD

- Discussion, Antoine Roumanos, PhD


Prevention

- Evidence-Based Prevention: A Positive Prevention Framework for Schools and Communities, Ms Susan Keister

- Developing Best Practice in Prevention, Mr Jeff Lee

- Discussion, Ms Mona Yazigi

- Cannabis et schizophrénie : que nous indiquent les données scientifiques ?, Philippe Nuss, MD

- Discussion, Ms Mona Yazigi


Regional Assessment

- Drug Abuse in the Countries of the Eastern Mediterranean Region of WHO, Ahmad Mohit, MD

- The Kermanshah Project in Iran: A Review of the Harm Reduction Programme, Arash Alaei, MD

- Discussion, Josyan Madi-Skaff, MD

- Substance Abuse in Lebanon and the Arab World: A Review of Epidemiological Studies, Elie G. Karam, MD & Ms Mariana M. Salamoun

- Discussion, William Lowenstein, MD


Synthesis

- Synthesis, Ms Sarah Trad
- Synthesis (arabic version)


Biographies